T2 biosystems, inc. (TTOO)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Cash flows from operating activities
Net loss

-14,949

-14,041

-14,171

-15,647

-15,147

-15,149

-10,767

-12,324

-12,913

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-15,457

-14,703

-

-12,783

-14,046

-13,426

-12,032

-11,644

-10,995

-10,619

-9,075

-8,092

-7,303

-6,920

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

500

503

522

572

600

587

638

595

629

746

762

738

694

654

558

539

529

486

379

347

253

232

160

155

144

Non-cash lease expense

394

-

-

-

342

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation expense

1,160

983

1,165

1,277

2,033

2,410

2,208

3,898

1,381

984

1,256

1,393

1,157

1,189

1,132

1,237

1,290

1,269

1,322

855

722

596

552

266

239

Change in fair value of derivative instrument

111

178

-100

-278

-83

-79

-184

217

142

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of property and equipment

629

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense

621

644

609

586

568

558

531

567

560

742

677

652

639

105

151

160

148

66

108

156

24

10

81

10

11

Change in fair value of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

74

-73

Deferred rent

-

-

-

-

-

55

56

54

52

20

21

21

53

63

64

63

60

33

19

49

18

10

-28

19

-6

Changes in operating assets and liabilities:
Accounts receivable

-371

1,252

394

-594

-13

52

141

1,011

115

25

-539

572

82

-52

91

-72

-9

-9

-11

301

-113

-

-

-

-

Prepaid expenses and other assets

278

-479

1,204

-1,028

401

-684

1,160

239

-145

4

96

-336

111

-186

394

-332

56

-218

475

-57

-390

316

893

-44

52

Inventories

-845

-550

582

741

141

-102

1,179

76

-64

-341

239

526

-314

-534

-98

176

576

-374

489

316

137

-

-

-

-

Accounts payable

-2,021

277

666

2,143

-126

161

-564

392

132

-345

-667

499

199

71

-83

-728

679

-81

-569

389

438

19

54

-374

93

Accrued expenses and other liabilities

-1,265

2,458

39

1,093

118

492

383

-472

-682

363

591

264

-494

-217

569

192

36

-43

699

113

-509

295

601

736

773

Deferred revenue

-61

-356

-88

-24

-31

-23

-189

154

-749

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities

-578

-566

-565

-394

-735

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

366

-318

-

-449

-470

-409

947

-576

-254

1,949

-

-

-

-

Net cash used in operating activities

-14,740

-10,119

-13,535

-8,840

-12,867

-9,688

-10,094

-8,614

-11,742

-11,077

-11,662

-12,221

-12,758

-10,299

-11,356

-12,951

-11,836

-

-

-

-

-

-

-

-

Cash flows from investing activities
Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-11,253

-9,998

-7,394

-8,485

-7,508

-6,400

-5,791

Purchases and manufacture of property and equipment

67

26

291

250

194

-357

351

543

56

-125

133

874

1,594

-

-

1,015

2,158

1,874

1,916

2,724

1,460

1,045

531

245

263

Net cash used in investing activities

-67

-26

-291

-250

-194

357

-351

-543

-56

125

-133

-874

-1,594

-893

-1,421

-1,015

-2,158

-

-

-

-

-

-

-

-

Cash flows from financing activities
Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,916

-2,644

-1,460

-1,045

-531

-245

-263

Payment of offering costs for issuance of common stock in public offering

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

15

370

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock and stock option exercises, net

-

-

-

-

-

-

481

1,119

4

-

4

374

339

282

36

399

301

636

80

713

375

-

-

-

-

Proceeds from issuance of common stock in public offering, net of offering costs

40,097

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Principal repayments of finance leases

-

0

320

218

344

453

378

364

352

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments of issuance costs for notes payable

-

-

-

-

-

-

-

-

-

-

-

-

354

-

-

-

0

-

-

-

-

-

-

-

-

Principal repayments of note payable

-

-

-

-

-

-

-

-

-

-

278

321

299

29,923

2,089

312

80

74

83

77

75

71

3,074

446

446

Net cash provided by (used in) financing activities

40,097

4,965

1,617

112

-344

-89

-40

50,134

-348

-146

18,558

407

-314

9,569

37,670

4,665

-149

-

-

-

-

-

-

-

-

Net increase (decrease) in cash, cash equivalents and restricted cash

25,290

-5,180

-12,209

-8,978

-13,405

-9,420

-10,485

40,977

-12,146

-11,098

6,763

-12,688

-14,666

-

-

-

-

-

-

-

-

-

-

-

-

Reconciliation of cash, cash equivalents and restricted cash at end of period
Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3

636

300

7,790

67,752

-1,177

-446

Net decrease in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

24,893

-9,301

-14,143

33,545

-13,172

-12,006

-8,554

-1,740

59,713

-7,822

-6,500

Supplemental disclosures of cash flow information
Cash paid for interest

906

1,224

1,168

1,136

1,131

927

929

958

972

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

-

993

-

735

629

517

396

394

395

321

221

169

74

51

Supplemental disclosures of noncash activities
Transfer of T2 owned instruments and components to (from) inventory

521

-39

490

-305

-154

-558

0

0

802

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrants issued and modified

-

-

-

-

147

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Transfer of T2 owned instruments and components to inventory

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Leasehold improvements paid by landlord

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,033

-

-

-

-

Right-of-use assets obtained in exchange for new operating lease liabilities

-

0

0

0

4,805

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment included in accounts payable and accrued expenses

50

64

-150

137

56

-29

8

-18

119

99

39

-10

61

-51

-51

52

132

-1,320

-28

1,263

332

-

-

-

-

Accretion of Series A-1, A-2, B, C, D and E redeemable convertible preferred stock to redemption value

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

758

1,906

1,906